Author of the development: Myrzaliev Akhan Zhakangerovich, Candidate of Vet.N. KazNIVI, +77014912512
The name of RNNTD: Hemolysin and complement for use in the serological diagnosis of brucellosis of animals.
Project description: Production of drugs for the diagnosis of infectious diseases in accordance with GMP requirements.
Competitive advantage: The drugs comply with GMP requirements and competitors in pricing.
Joint participation in the competition for grant financing of RNNTD commercialization projects on co-financing terms.
The introduction of technology on the terms of a share of excess profits (Conclusion of a license agreement).
Enterprises and companies most suitable for partnership: Pharmaceutical companies, veterinary companies.